REMEDY PLAN, INC.

Profile

Company Names

REMEDY PLAN, INC.

Addresses

704 QUINCE ORCHARD RD, SUITE 220, GAITHERSBURG, MD 20878

704 QUINCE ORCHARD ROAD, SUITE 220, GAITHERSBURG, MD 20878

12111 PARKLAWN DRIVE, ROOM 120, ROCKVILLE, MD 20852

Phone Numbers

2404593985
240-459-3985
5105520105

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY, PHARMACEUTICALS

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$25,769,387.00

Number of Funding Rounds:

3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2023-07-28 
$19,069,387.00 
$19,579,386.00 
$509,999.00 
Equity 
2
2019-11-12 
$5,200,000.00 
$7,200,000.00 
$2,000,000.00 
Equity 
1
2018-11-09 
$1,500,000.00 
$1,500,000.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
GREGORY 
 
CRIMMINS 
EXECUTIVE OFFICER, DIRECTOR
REMEDY PLAN, INC.
GREGORY 
PLAN 
CRIMMINS 
EXECUTIVE OFFICER, DIRECTOR
REMEDY PLAN, INC.
OWEN 
 
HUGHES 
DIRECTOR
RANA THERAPEUTICS, INC.   |  TRANSLATE BIO, INC.   |  CULLINAN MICA CORP.   |  REMEDY PLAN, INC.   |  IKENA ONCOLOGY, INC.   |  STIPPLE BIO, INC.
ALEXANDRA 
 
MANICK 
DIRECTOR
REMEDY PLAN, INC.   |  JETCOOL TECHNOLOGIES INC.   |  AMPLIFIED INDUSTRIES, INC.
FRANK 
 
MCCORMICK 
DIRECTOR
EXELIXIS INC   |  ADURO BIOTECH   |  ADURO BIOTECH, INC.   |  AVIDITY NANOMEDICINES LLC   |  PELLEPHARM, INC.   |  OLEMA PHARMACEUTICALS, INC.   |  REMEDY PLAN, INC.   |  EXUMA BIOTECH CORP.   |  THERAS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2023-08-10
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2023-07-28 
2019-12-02
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-11-12 
2018-11-20
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2018-11-09 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#